← Back to Neuland Laboratories Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
NEULANDLABPharmaceuticals

Neuland Laboratories Ltd — Financial Ratios & Key Metrics

₹12027.00
-1.94%
P/E Ratio108.36xIndustry: 31.77x
ROE14.83%Return on equity
ROCE18.66%Return on capital
Debt/Equity0.16Low debt
💎

Valuation & Profitability

P/E Ratio
108.36x
Industry Average P/E
31.77x
Dividend Yield
0.07%
Market Cap
₹21.22K (Cr)
Sales Growth 5Y
14.13%
Profit Growth 5Y
66.88%
EPS Growth 5Y
66.88%
OPM 5Y Avg
22.21%
📉

Price Returns

1 Month
+0.69%
3 Months
+20.83%
6 Months
+40.65%
1 Year
-0.73%
52W Low
₹10400
Current
₹12027
52W High
₹19747
17% of 52-week range — Near lows
🔬

Technical Indicators

36RSI 14
Neutral
Momentum is balanced — neither overbought nor oversold.
SMA 50
₹13010
▼ Price below SMA 50 — Bearish
SMA 200
₹14355
▼ Long-term downtrend
Volume Signal
138% of avg
Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Neuland Laboratories Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.